Assyro AI

Orange Book product · Generic (ANDA)

CLOPIDOGREL BISULFATE

CLOPIDOGREL BISULFATE

Generic (ANDA)ANDA 091023TE ABRX DR REDDYS LABS LTD
View CLOPIDOGREL BISULFATE familyOpen on FDA Orange Book

At a glance

Aug 05, 2024

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 05, 2024

    1 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

CLOPIDOGREL BISULFATE

Strength

EQ 75MG BASE

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 091023

Product number

002

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of CLOPIDOGREL BISULFATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo